Literature DB >> 1306102

HLA and multiple myeloma among black and white men: evidence of a genetic association.

L M Pottern1, J J Gart, J M Nam, G Dunston, J Wilson, R Greenberg, J Schoenberg, G M Swanson, J Liff, A G Schwartz.   

Abstract

To evaluate the possibility that genetic factors contribute to the excess rates of multiple myeloma among blacks, serological typing of human leukocyte antigens (HLA) was conducted for black and white male patients and controls who participated in a large population-based case-control interview study. Forty-six black cases, 88 black controls, 85 white cases, and 122 white controls were typed for the Class I antigens (HLA-A, -B, -C) and for the Class II antigens (HLA-DR, HLA-DQ). Black cases had significantly higher gene frequencies than black controls for Bw65, Cw2, and DRw14, while white cases had higher gene frequencies than white controls for A3 and Cw2 and blanks at the DR and DQ loci. Further analysis of the association between Cw2 and multiple myeloma revealed relative risks of 5.7 (95% confidence interval = 1.5-26.6) and 2.6 (95% confidence interval = 1.0-7.2) for blacks and whites, respectively. The frequency of Cw2 in black and white controls was similar. These findings suggest that the Cw2 allele enhances the risk of myeloma in blacks and whites but do not explain the higher incidence of this cancer among blacks. The study also suggests that undefined DQ antigens may play an etiological role, supporting the need for further research into the immunogenetic determinants of myeloma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1306102

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  8 in total

1.  Socioeconomic status and multiple myeloma among US blacks and whites.

Authors:  D Baris; L M Brown; D T Silverman; R Hayes; R N Hoover; G M Swanson; M Dosemeci; A G Schwartz; J M Liff; J B Schoenberg; L M Pottern; J Lubin; R S Greenberg; J F Fraumeni
Journal:  Am J Public Health       Date:  2000-08       Impact factor: 9.308

Review 2.  Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites.

Authors:  A J Greenberg; C M Vachon; S V Rajkumar
Journal:  Leukemia       Date:  2011-12-23       Impact factor: 11.528

3.  A duplicated region is responsible for the poly(ADP-ribose) polymerase polymorphism, on chromosome 13, associated with a predisposition to cancer.

Authors:  D Lyn; B W Cherney; M Lalande; J R Berenson; A Lichtenstein; S Lupold; K G Bhatia; M Smulson
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

4.  Inherited predisposition to multiple myeloma.

Authors:  Divya T Koura; Amelia A Langston
Journal:  Ther Adv Hematol       Date:  2013-08

Review 5.  Differences in cancer incidence, mortality, and survival between African Americans and whites.

Authors:  B Walker; L W Figgs; S H Zahm
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

6.  The Association of HLA Class 1 and Class 2 Antigens with Multiple Myeloma in Iranian Patients.

Authors:  Arezou Sayad; Mohammad Taghi Akbari; Mahshid Mehdizadeh; Elham Roshandel; Soheila Abedinpour; Abbas Hajifathali
Journal:  Turk J Haematol       Date:  2014-12-05       Impact factor: 1.831

7.  Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical features.

Authors:  MaryAnn E VanValkenburg; Gwendolyn I Pruitt; Ilene K Brill; Luciano Costa; Maryam Ehtsham; Ian T Justement; Racquel D Innis-Shelton; Donna Salzman; E Shyam P Reddy; Kelly N Godby; Fady M Mikhail; Andrew J Carroll; Vishnu B Reddy; Ralph D Sanderson; Louis B Justement; Paul W Sanders; Elizabeth E Brown
Journal:  Cancer Causes Control       Date:  2015-11-23       Impact factor: 2.506

8.  Findings of Multiple Myeloma in Afro-Caribbean Patients in the United States.

Authors:  Ashtami Banavali; Elvira Neculiseanu; Padma L Draksharam; Sireesha Datla; Maushmi Savjani; Jennifer Park; Gurinder Sidhu; Evelyn O Taiwo
Journal:  J Glob Oncol       Date:  2018-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.